Resolution of hyperacusis associated with depression, following lithium administration and directive counselling

J Laryngol Otol. 2010 Aug;124(8):919-21. doi: 10.1017/S0022215109992258. Epub 2009 Dec 23.

Abstract

Introduction: Hyperacusis may be described as a decreased threshold for discomfort from sound. It may have a serious impact on an individual's lifestyle, as a result of decreased sociability and inability to spend time with family and friends due to intolerance of sound.

Subject: We present a case of hyperacusis associated with depression, with no other audiological abnormality. The patient reported greater difficulty during the depressive episode.

Method: Audiological investigation was undertaken, followed by counselling and medication for depression.

Results and conclusion: The pathophysiological mechanism of hyperacusis in depression is discussed. Outcomes following treatment with directive counselling and lithium (an antidepressant) are described. Research indicates that both hyperacusis and depression can be caused by hypoactivity of 5-hydroxytryptamine (also known as serotonin) in the brain. The patient reported improvement which cannot be explained solely on the basis of counselling. Enhancement of serotonin activity due to lithium, prescribed for depression, may also play a role in alleviation of hyperacusis.

Publication types

  • Case Reports

MeSH terms

  • Antidepressive Agents / therapeutic use
  • Audiometry
  • Depression / complications
  • Depression / drug therapy*
  • Directive Counseling
  • Female
  • Humans
  • Hyperacusis / psychology
  • Hyperacusis / therapy*
  • Lithium Compounds / therapeutic use
  • Self Report
  • Serotonin / physiology
  • Treatment Outcome
  • Young Adult

Substances

  • Antidepressive Agents
  • Lithium Compounds
  • Serotonin